TBK1: A key regulator and potential treatment target for interferon positive Sjogren's syndrome, systemic lupus erythematosus and systemic sclerosis

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)97-102
Number of pages6
JournalJournal of Autoimmunity
Volume91
DOIs
Publication statusPublished - 2018

Cite this